NWI Management’s Acceleron Pharma XLRN Stock Holding History

NWI Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200,000	Closed	-$34.4M	–	55
2021 Q3	$34.4M	Hold	200,000	–	–	2.13%	13
2021 Q2	$25.1M	Hold	200,000	–	–	1.54%	17
2021 Q1	$27.1M	Hold	200,000	–	–	2.26%	14
2020 Q4	$25.6M	Hold	200,000	–	–	2.54%	14
2020 Q3	$22.5M	Buy	+200,000	New	+$19.9M	1.95%	13

NWI Management's XLRN Position: Q4 2021 in Review

NWI Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 200,000 shares — an estimated $34.4M sold.

NWI Management first reported a position in XLRN in Q3 2020 and held it in 5 quarters. The position peaked at $34.4M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

NWI Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
NWI Management sold 200,000 Acceleron Pharma shares in Q4 2021, an estimated $34.4M.
NWI Management first reported a position in Acceleron Pharma in Q3 2020 and held it in 5 quarters.
NWI Management's Acceleron Pharma position peaked at $34.4M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on NWI Management's 13F filing for Q4 2021, filed 14 Feb 2022.